FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical composition for treatment of hyperlipidemia. Pharmaceutical composition for treatment of hyperlipidemia comprises a hypolipidemic drug selected from atorvastatin, lovastatin, rosuvastatin, simvastatin, pravastatin, pitavastatin, fluvastatin, and a glycyrrhizin derivative selected from glycyrrhizic acid or a pharmaceutically acceptable salt thereof in a weight ratio of 1:0.5 to 1:200.
EFFECT: pharmaceutical composition for treatment of hyperlipidemia has been proposed.
1 cl, 35 tbl, 2 ex
Authors
Dates
2019-04-01—Published
2017-06-07—Filed